242 related articles for article (PubMed ID: 25039399)
1. Adenocarcinoma arising from intracranial recurrent mature teratoma and featuring mutated KRAS and wild-type BRAF genes.
Kim ES; Kwon MJ; Song JH; Kim DH; Park HR
Neuropathology; 2015 Feb; 35(1):44-9. PubMed ID: 25039399
[TBL] [Abstract][Full Text] [Related]
2. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.
Hershkovitz D; Vlodavsky E; Simon E; Ben-Izhak O
Pathol Int; 2013 Dec; 63(12):611-4. PubMed ID: 24422958
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
4. Histopathological and molecular features of late relapses in non-seminomas.
Mayer F; Wermann H; Albers P; Stoop H; Gillis AJ; Hartmann JT; Bokemeyer CC; Oosterhuis JW; Looijenga LH; Honecker F
BJU Int; 2011 Mar; 107(6):936-43. PubMed ID: 20955261
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma.
Stanhiser J; Mahdi H; Rosa G; Harper H; Shepard D; Rose PG; Roma AA
Int J Gynecol Pathol; 2016 Mar; 35(2):185-90. PubMed ID: 26352547
[TBL] [Abstract][Full Text] [Related]
6. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
[TBL] [Abstract][Full Text] [Related]
7. Intestinal adenocarcinoma arising in a mature cystic teratoma of the ovary: a case report.
Min KJ; Jee BC; Lee HS; Kim YB
Pathol Res Pract; 2006; 202(7):531-5. PubMed ID: 16713128
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor expression and KRAS and BRAF mutations: study of 39 sinonasal intestinal-type adenocarcinomas.
Projetti F; Durand K; Chaunavel A; Léobon S; Lacorre S; Caire F; Bessède JP; Moreau JJ; Coulibaly B; Labrousse F
Hum Pathol; 2013 Oct; 44(10):2116-25. PubMed ID: 23791006
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal and retroperitoneal teratoma with focal gastrointestinal adenocarcinoma.
Chang YL; Wu CT; Lee YC
J Thorac Oncol; 2006 Sep; 1(7):729-31. PubMed ID: 17409945
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
11. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
Schweiger T; Hegedüs B; Nikolowsky C; Hegedüs Z; Szirtes I; Mair R; Birner P; Döme B; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
[TBL] [Abstract][Full Text] [Related]
12. Caudal Homeobox Gene-2 Staining Defines Intracranial Mature Teratoma with Differentiation to Colonic Adenocarcinoma.
Riedy LN; Kim M; Yun JJ; Borys E; Prabhu VC
World Neurosurg; 2019 Dec; 132():239-244. PubMed ID: 31520753
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of intracranial mature teratoma to yolk sac tumor after late relapse. Case report.
Utsuki S; Oka H; Sagiuchi T; Shimizu S; Suzuki S; Fujii K
J Neurosurg; 2007 Jun; 106(6):1067-9. PubMed ID: 17564180
[TBL] [Abstract][Full Text] [Related]
14. Mature cystic teratoma with malignant transformation to adenocarcinoma.
Muramatsu T; Nishii T; Ohmori K; Shiono M
Ann Thorac Surg; 2011 Jun; 91(6):1971-3. PubMed ID: 21619995
[TBL] [Abstract][Full Text] [Related]
15. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.
Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M
Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218
[TBL] [Abstract][Full Text] [Related]
16. KRAS mutation in adenocarcinoma of the gastrointestinal type arising from a mature cystic teratoma of the ovary.
Li Y; Zhang R; Pan D; Huang B; Weng M; Nie X
J Ovarian Res; 2014 Sep; 7():85. PubMed ID: 25297496
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.
Shibata T; Hanada S; Kokubu A; Matsuno Y; Asamura H; Ohta T; Sakamoto M; Hirohashi S
Cancer Sci; 2007 Jul; 98(7):985-91. PubMed ID: 17459062
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
19. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary.
Levine DA; Villella JA; Poynor EA; Soslow RA
Gynecol Oncol; 2004 Aug; 94(2):597-9. PubMed ID: 15297213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
